Product
131 I-DGT-207
BIOTECHNOLOGY
bydGenThera
United States (US)
ABOUT THE PRODUCT
A bioligand-tagged conjugate demonstrating superior biodistribution compared to other I-131 TRTs in an undisclosed human cancer xenograft model, showcasing the effectiveness of matching tag and ligand physicochemical properties.
Information is owner-confirmed
Last updated 2 months ago
Price range